Custom Search

News

Monday 01 March 2004

Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devices.

By: Metcalfe S, Moodie P.

J Allergy Clin Immunol 2004 Mar;113(3):568-9; author reply 569-71

No abstract available

Use of this site is subject to the following terms of use